Joris Winderickx
Corporate Officer/Principal at reMYND NV
Profile
Joris Winderickx is the founder of reMYND NV, where he currently serves as the Scientific Advisor since 2012.
He founded the company in 2002.
Dr. Winderickx is also the founder of Royal Flemish Chemical Society.
Dr. Winderickx's former job includes being a Director at ADx NeuroSciences NV.
Additionally, he worked as a Professor at Katholieke Universiteit Leuven.
Dr. Winderickx's education includes a doctorate degree from Katholieke Universiteit Leuven.
Joris Winderickx active positions
Companies | Position | Start |
---|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Corporate Officer/Principal | 2012-05-29 |
Former positions of Joris Winderickx
Companies | Position | End |
---|---|---|
Royal Flemish Chemical Society | Founder | - |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Director/Board Member | - |
Katholieke Universiteit Leuven | Corporate Officer/Principal | - |
Training of Joris Winderickx
Katholieke Universiteit Leuven | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |
Royal Flemish Chemical Society |
- Stock Market
- Insiders
- Joris Winderickx